Impopharma

Impopharma is a pharmaceutical development company with state-of-the-art GMP/OECD Good Laboratory Practice (GLP) compliant facilities, specializing in providing development services for various dosage forms, including: nasal and pulmonary inhalation products, pressurized metered-dose inhalers (pMDI) solutions, suspension dry powder inhalers (DPI), nasal spray solutions, sublingual spray suspensions, as well as formulation development, analytical development, process development, equipment development, regulatory support, technology transfer, and on-site (at the customer’s or Impopharma's facilities) training.